Lacticin 481: In Vitro Reconstitution of Lantibiotic Synthetase Activity

Science

Volumn 303, Issue 5658, 2004, Pages 679-681

  Xie, Lili ^a   Miller, Leah M ^a   Chatterjee, Champak ^a   Averin, Olga ^a   Kelleher, Neil L ^a   Van Der Donk, Wilfred A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIBIOTICS; CATALYSIS; CHEMICAL BONDS; DEHYDRATION;

MUTANTS;

ENZYMES;

LACTICIN 481; LANTIBIOTIC; SERINE; SYNTHETASE; THREONINE; UNCLASSIFIED DRUG;

MEDICINE;

ARTICLE; BIOSYNTHESIS; CATALYSIS; CHEMICAL BOND; DEHYDRATION; ENZYME ACTIVITY; ENZYME RECONSTITUTION; ENZYME SUBSTRATE; IN VITRO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; RIBOSOME;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BACTERIOCINS; CLONING, MOLECULAR; CYSTEINE; ENZYMES; ESCHERICHIA COLI; LACTOCOCCUS LACTIS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SERINE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY; THREONINE;

EID: 0942268866     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1092600     Document Type: Article

References (29)

1. E. Breukink et al., Science 286, 2361 (1999).
2. T. R. Klaenhammer, FEMS Microbiol. Rev. 12, 39 (1993).
3. H. G. Sahl, G. Bierbaum, Annu. Rev. Microbiol. 52, 41 (1998).
4. H. W. van den Hooven et al., FEBS Lett. 391, 317 (1996).
5. J. Delves-Broughton, P. Blackburn, R. J. Evans, J. Hugenholtz, Antonie Van Leeuwenhoek 69, 193 (1996).
6. W. Liu, J. N. Hansen, J. Biol. Chem. 267, 25078 (1992).
7. O. P. Kuipers et al., Antonie Van Leeuwenhoek 69, 161 (1996).
8. P. Chen et al., Appl. Environ. Microbiol. 64, 2335 (1998).
9. C. Szekat, R. W. Jack, D. Skutlarek, H. Farber, G. Bierbaum, Appl. Environ. Microbiol. 69, 3777 (2003).
10. Lack of lantibiotic production may be due to disruption of the posttranslational modification process, degradation of the non-native peptide product or intermediates, breakdown of self-immunity resulting in shutdown of production, or perturbation of signaling pathways in cases in which the bacteriocin acts as a quorum sensor controlling its own expression. See references (25-28).
11. N. Schnell et al., Nature 333, 276 (1988).
12. A. Rincé, A. Dufour, P. Uguen, J. P. Le Pennec, D. Haras, Appl. Environ. Microbiol. 63, 4252 (1997).
13. J. C. Piard, O. P. Kuipers, H. S. Rollema, M. J. Desmazeaud, W. M. de Vos, J. Biol. Chem. 268, 16361 (1993).
14. O. Koponen et al., Microbiol. 148, 3561 (2002).
15. R. J. Siezen, O. P. Kuipers, W. M. de Vos, Antonie Van Leeuwenhoek 69, 171 (1996).
16. Materials and methods are available as supporting material on Science Online.
17. 6-tag linker is GSSHHHHHHSSGLVPRGSH. The DNA sequences of all constructs were verified and the masses of the expressed gene products were determined by mass spectrometry.
18. N. M. Okeley, M. Paul, J. P. Stasser, N. Blackburn, W. A. van der Donk, Biochemistry 42, 13613 (2003).
19. F. W. McLafferty, E. K. Fridriksson, D. M. Horn, M. A. Lewis, R. A. Zubarev, Science 284, 1289 (1999).
20. P. Roepstorff, J. Fohlman, Biomed. Mass Spectrom. 11, 601 (1984).
21. A. J. Kleinnijenhuis, M. C. Duursma, E. Breuking, R. M. A. Heeren, A. J. R. Heck, Anal. Chem. 75, 3219 (2003).
22. Y. M. Li, J. C. Milne, L. L. Madison, R. Kolter, C. T. Walsh, Science 274, 1188 (1996).
23. T. W. Muir, D. Sondhi, P. A. Cole, Proc. Natl. Acad. Sci. U.S.A. 95, 670S (1998).
24. L. Xie, thesis, University of Illinois, Urbana-Champaign (2003).
25. J. R. van der Meer et al., J. Biol. Chem. 269, 3555 (1994).
26. O. P. Kuipers, M. M. Beerthuyzen, P. G. de Ruyter, E. J. Luesink, W. M. de Vos, J. Biol. Chem. 270, 27299 (1995).
27. M. Reis, M. Eschbach-Bludau, M. I. Iglesias-Wind, T. Kupke, H. G. Sahl, Appl. Environ. Microbiol. 60, 2876 (1994).
28. G. Bierbaum, M. Reis, C. Szekat, H. G. Sahl, Appl. Environ. Microbiol. 60, 4332 (1994).
29. This work was supported by grants from the National Institutes of Health to W.A.V. (GM58822) and N.L.K. (GM 067725), the Beckman Foundation, and the Burroughs Wellcome Fund (APP 1920 to W.A.V.).